251 results on '"Junge S"'
Search Results
2. 34 Mucoid Staphylococcus aureus in the airways of people with cystic fibrosis are associated with small colony variants
3. P242 Small colony variants of Staphylococcus aureus often exhibit a mucoid phenotype in the airways of people with cystic fibrosis
4. Monitoring Rail Condition Based on Sound and Vibration Sensors Installed on an Operational Train
5. Enhancing classification efficiency in capsule networks through windowed routing: tackling gradient vanishing, dynamic routing, and computational complexity challenges
6. Zystische Fibrose
7. 536 Not only 5–base pair deletions in the intergenic region of the intercellular adhesion operon, but also mutations in the repressor of the intercellular adhesion operon lead to a mucoid phenotype in Staphylococcus aureus residing in the airways of people with cystic fibrosis
8. 1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO
9. LBA59 Modified FOLFOX plus/minus nivolumab and ipilimumab vs FLOT plus nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Final results of the IKF-AIO-Moonlight trial
10. OBSOLETE: Respiratory Syncytial Virus
11. ePS3.01 Preliminary results of an ongoing study, which determines the prevalence and possible impact of mucoid Staphylococcus aureus on lung disease of people with cystic fibrosis
12. Surveying in the Dutch Colonial Archive: reproduction, authorship, and postcolonial ownership
13. Introduction: survey practices across the globe
14. Messung der b-adrenergen Schweißsekretionsrate als neues hochsensitives Diagnostikverfahren bei Zystischer Fibrose und anderen CFTR-vermittelten Erkrankungen
15. 1535P Paclitaxel + ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the oesophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs: Final results from the randomized phase II IKF-S627/RAMOS trial of the AIO
16. Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis
17. Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients
18. Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer : The RAMTAS trial of the German AIO
19. P053 Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depend on age and lung disease severity
20. EPS3.08 Evaluation of a fixed-step eradication regime in children with cystic fibrosis and detection of Pseudomonas aeruginosa
21. P010 Newborn screening for cystic fibrosis improves nutritional outcome: monocentric data of the first 4 years in Germany
22. Recombinant allergens in the differentiation of food allergies: FT10 – Talk Junge
23. Respiratory Syncytial Virus
24. MOLECULAR ANALYSIS OF STAPHYLOCOCCUS AUREUS ISOLATES FROM AN ONGOING PROSPECTIVE OBSERVATIONAL LONGITUDINAL MULTICENTER STUDY DETERMINING STAPHYLOCOCCUS AUREUS AIRWAY COLONIZATION OR INFECTION IN CYSTIC FIBROSIS PATIENTS: 307
25. 1443P Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction – Safety Results from AIO-STO-0417: A randomized phase II trial of the German Gastric Group of the AIO
26. 438P Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer: The RAMTAS trial of the German AIO
27. 1502TiP Paclitaxel + ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the esophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs - RAMOS, a randomized phase II trial of the German Gastric Group of the AIO
28. P293 Physical activity in children and adolescents with cystic fibrosis – do they move enough?
29. WS09.1 ICM and NPD diagnostics of cases with inconclusive CFTR genetics and sweat test: a single-centre 10-year experience
30. P321 Respiratory physiotherapy for children and adolescents with cystic fibrosis – is there a link between adherence and clinical health status?
31. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11·2 microdeletion and partial DiGeorge syndrome
32. A NEW DEVICE FOR MEASURING PHYSICAL ACTIVITY IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS (CF): 522
33. AGE AND SEX RELATED PHYSICAL ACTIVITY IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS (CF): 521
34. LONG-TERM EFFECTS OF A 6-MONTH HOME-BASED NON-SUPERVISED PHYSICAL CONDITIONING PROGRAM IN CYSTIC FIBROSIS: 512⋆
35. THE FIRST FOUR YEARS AFTER THE INITIAL P. AERUGINOSA COLONIZATION: ERADICATION VERSUS SUPPRESSION: 393
36. A Novel Sidestream Ultrasonic Flow Sensor for Multiple Breath Washout in Children
37. Evaluation eines ganzheitlichen, Patienten-zentrierten Versorgungsmodells für Patienten mit seltenen Erkrankungen unter besonderer Berücksichtigung der psychosozialen Versorgung am Beispiel Mukoviszidose – VEMSE-CF
38. Low-dose methotrexate for advanced pulmonary disease in patients with cystic fibrosis
39. Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase II trial of the German Gastric Group of the AIO
40. P469 From paediatric to adult care - improvement of a structural program of transition at the Cystic Fibrosis Centre of Hannover Medical School
41. P201 Adherence in nebulisation therapy of paediatric patients with cystic fibrosis
42. Zwei Jahre später – monozentrische Erfahrungen mit dem Neugeborenen-Screening auf Mukoviszidose
43. 237Prevalence of infective endocarditis in enterococcus faecalis bacteraemia: a prospective multicenter screening study
44. The influence of oil price uncertainty on corporate debt risk: Evidence from China
45. IPD2.12 Respiratory physiotherapy for children with cystic fibrosis at infancy and early childhood – an actual state-target-analysis in consideration of parental influences on therapy adherence
46. Factors associated with worse lung function in cystic fibrosis patients with persistent staphylococcus aureus
47. Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
48. 835TiP - Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase II trial of the German Gastric Group of the AIO
49. Quality of life is associated with physical activity and fitness in cystic fibrosis
50. High Pressure Processing of meat and Seafood
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.